Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention (Q37700962)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 May 2008

Language	Label	Description	Also known as
English	Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention	scientific article published on 18 May 2008

Statements

scholarly article

1 reference

Europe PubMed Central

22 August 2017

Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention (English)

1 reference

Europe PubMed Central

22 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M Scott Lucia

1

1 reference

Europe PubMed Central

22 August 2017

Amy K Darke

2

1 reference

Europe PubMed Central

22 August 2017

Phyllis J Goodman

3

1 reference

Europe PubMed Central

22 August 2017

Francisco G La Rosa

4

1 reference

Europe PubMed Central

22 August 2017

Howard L Parnes

5

1 reference

Europe PubMed Central

22 August 2017

Leslie G Ford

6

1 reference

Europe PubMed Central

22 August 2017

Charles A Coltman

7

1 reference

Europe PubMed Central

22 August 2017

Ian M Thompson

8

1 reference

Europe PubMed Central

22 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 May 2008

1 reference

Europe PubMed Central

22 August 2017

Cancer Prevention Research

1 reference

Europe PubMed Central

22 August 2017

1

1 reference

Europe PubMed Central

22 August 2017

3

1 reference

Europe PubMed Central

22 August 2017

167-173

1 reference

Europe PubMed Central

22 August 2017

What to do with an abnormal PSA test.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

23 August 2017

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

23 August 2017

Quantifying the role of PSA screening in the US prostate cancer mortality decline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

23 August 2017

Prostate cancers in men with low PSA levels--must we find them?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

23 August 2017

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

23 August 2017

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

23 August 2017

The influence of finasteride on the development of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

23 August 2017

Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

23 August 2017

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

23 August 2017

The role of increasing detection in the rising incidence of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

23 August 2017

Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

6 September 2017

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

14 September 2017

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

14 September 2017

Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

14 September 2017

Prospective evaluation of men with stage T1C adenocarcinoma of the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

23 June 2018

Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

1 September 2018

Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

1 September 2018

Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

1 September 2018

Whitmoreisms: memorable quotes from Willet F. Whitmore, Jr, M.D.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

1 September 2018

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

1 September 2018

Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3985428

1 September 2018

Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/19138952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19138952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19138952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19138952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Follow-up prostate cancer treatments after radical prostatectomy: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19138952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19138952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimated impact of the prostate cancer prevention trial on population mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/19138952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/19138952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relating biopsy and clinical variables to radical prostatectomy findings: Can insignificant and advanced prostate cancer be predicted in a screening population?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19138952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1940-6207.CAPR-08-0078

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

22 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37700962&oldid=2157855283"